TM6SF2 and hepatocellular carcinoma: However, Gellert-Kristensen et al. reported that a genetic risk score comprising three common variants in PNPLA3, TM6SF2, and HSD17B13 (rs72613567) was associated with up to 12-fold higher risk of cirrhosis and up to 29-fold higher risk of HCC [80].